Clinical Trial Update: Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tranexamic acid to reduce hemorrhagic events during bariatric surgery, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Patel Hospital, Pakistan | Conditions: Hemorrhage, Bariatric Surgery | Phase 4 | Status: RECRUITING